Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

BACKGROUND: The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy. METHODS: To evaluate the variables that determined the choice of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gori, Stefania, Clavarezza, Matteo, Siena, Salvatore, Foglietta, Jennifer, Tarenzi, Emiliana, Giordano, Monica, Molino, Annamaria, Graiff, Claudio, Fusco, Vittorio, Alabiso, Oscar, Baldini, Editta, Gamucci, Teresa, Altavilla, Giuseppe, Dondi, Davide, Venturini, Marco
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3404902/
https://ncbi.nlm.nih.gov/pubmed/22545982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-158
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki